Simulations Plus Advances Agentic Drug Development with NVIDIA BioNeMo Agent Toolkit

Stock Information for Simulations Plus Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Simulations Plus Inc.

Halper Sadeh LLC is Investigating Whether ALOT, SLP, OLN are Obtaining Fair Deals for their Shareholders
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-OLN, ALOT, SLP, and CZNL
Are ROKU, SLP, NUVL, DAN Obtaining Fair Deals for their Shareholders?
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq - APGE), Simulations Plus, Inc. (Nasdaq - SLP), Roku, Inc. (Nasdaq - ROKU), TruBridge, Inc. (Nasdaq - TBRG)
Simulations Plus (SLP) Investigation: Investors Who Suffered Losses Encouraged to Contact Johnson Fistel
Halper Sadeh LLC is Investigating Whether SLP, LPRO, HUN are Obtaining Fair Deals for their Shareholders
Simulations Plus, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - SLP
Simulations Plus Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Simulations Plus, Inc. - SLP

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.